%0 Journal Article
%T The Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults.
%A Painter JT
%A Peng C
%A Burlette M
%A Clement C
%A Luciani L
%A Azhar G
%A Dayer L
%J J Pain Palliat Care Pharmacother
%V 0
%N 0
%D 2024 Jun 10
%M 38857121
暂无%R 10.1080/15360288.2024.2358953
%X Falls pose a significant threat to older adults, resulting in injuries and mortality. Concurrently prescribed opioids and gabapentin for pain management may increase fall risks in older patients. This study aimed to estimate fall risks associated with the concurrent use of gabapentin and opioids, comparing them to opioid monotherapy in older adults. A retrospective case-control study of 1,813 patients aged 65-89 on chronic opioid therapy (2017-2020), excluding those with a fall history, analysis focused on the first fall occurrence. Logistic regression assessed the association between concurrent gabapentin and opioid use and fall events. Out of eligible patients, 122 (6.73%) experienced falls during opioid therapy, with 232 (12.80%) having concurrent gabapentin use. Concurrent use significantly increased fall risk (AOR = 1.73; 95% CI: 1.08-2.78). Being female, aged ≥81, and having more chronic conditions also increased risk. Mitigating fall risk in older adults requires education on prevention, exploring alternative pain management, and careful consideration of prescribing. Further research is crucial to understand adverse events linked to combined opioid and gabapentin use in the geriatric population.